741 related articles for article (PubMed ID: 17914249)
21. Cyclosporine in patients with steroid-resistant nephrotic syndrome: an open-label, nonrandomized, retrospective study.
Ghiggeri GM; Catarsi P; Scolari F; Caridi G; Bertelli R; Carrea A; Sanna-Cherchi S; Emma F; Allegri L; Cancarini G; Rizzoni GF; Perfumo F
Clin Ther; 2004 Sep; 26(9):1411-8. PubMed ID: 15531003
[TBL] [Abstract][Full Text] [Related]
22. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.
Li X; Li H; Ye H; Li Q; He X; Zhang X; Chen Y; Han F; He Q; Wang H; Chen J
Am J Kidney Dis; 2009 Jul; 54(1):51-8. PubMed ID: 19406543
[TBL] [Abstract][Full Text] [Related]
23. Proteomic profiling identifies haptoglobin as a potential serum biomarker for steroid-resistant nephrotic syndrome.
Wen Q; Huang LT; Luo N; Wang YT; Li XY; Mao HP; Zhang L; Dong XQ; Yu XQ
Am J Nephrol; 2012; 36(2):105-13. PubMed ID: 22759352
[TBL] [Abstract][Full Text] [Related]
24. NGAL distinguishes steroid sensitivity in idiopathic nephrotic syndrome.
Bennett MR; Piyaphanee N; Czech K; Mitsnefes M; Devarajan P
Pediatr Nephrol; 2012 May; 27(5):807-12. PubMed ID: 22200895
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of steroids, cyclosporin and cyclophos-phamide in steroid resistant idiopathic nephrotic syndrome.
Hafeez F; Ahmad TM; Anwar S
J Coll Physicians Surg Pak; 2005 Jun; 15(6):329-32. PubMed ID: 15924835
[TBL] [Abstract][Full Text] [Related]
26. Correlation of fractional excretion of magnesium with steroid responsiveness in children with nephrotic syndrome.
Rumana J; Hanif M; Muinuddin G; Maruf-Ul-Quader M
Saudi J Kidney Dis Transpl; 2014 Jul; 25(4):830-6. PubMed ID: 24969196
[TBL] [Abstract][Full Text] [Related]
27. Cyclosporine utilization in idiopathic nephrotic syndrome in children.
Saeed B; Ossman MI; Sheriff S
Saudi J Kidney Dis Transpl; 2006 Dec; 17(4):497-502. PubMed ID: 17186683
[TBL] [Abstract][Full Text] [Related]
28. Indications for kidney biopsy in idiopathic childhood nephrotic syndrome.
Alshami A; Roshan A; Catapang M; Jöbsis JJ; Kwok T; Polderman N; Sibley J; Sibley M; Mammen C; Matsell DG;
Pediatr Nephrol; 2017 Oct; 32(10):1897-1905. PubMed ID: 28540445
[TBL] [Abstract][Full Text] [Related]
29. Cyclosporine in steroid dependent and resistant childhood nephrotic syndrome.
Iyengar A; Karthik S; Kumar A; Biswas S; Phadke K
Indian Pediatr; 2006 Jan; 43(1):14-9. PubMed ID: 16465001
[TBL] [Abstract][Full Text] [Related]
30. Cyclosporine in idiopathic nephrotic syndrome.
Ponticelli C
Immunopharmacol Immunotoxicol; 1993 Aug; 15(4):479-89. PubMed ID: 8227973
[TBL] [Abstract][Full Text] [Related]
31. Circulating VEGF and TGF-beta1 in children with idiopathic nephrotic syndrome.
Cheong HI; Lee JH; Hahn H; Park HW; Ha IS; Choi Y
J Nephrol; 2001; 14(4):263-9. PubMed ID: 11506248
[TBL] [Abstract][Full Text] [Related]
32. Glomerular malondialdehyde levels in patients with focal and segmental glomerulosclerosis and minimal change disease.
Nezhad ST; Momeni B; Basiratnia M
Saudi J Kidney Dis Transpl; 2010 Sep; 21(5):886-91. PubMed ID: 20814126
[TBL] [Abstract][Full Text] [Related]
33. [Study on the differentially expressed genes of steroid-resistant and steroid-sensitive nephrotic syndrome].
Chen RY; Yu L; Hao ZH; Wang LN; Wen YQ
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Aug; 26(4):446-51. PubMed ID: 20017314
[TBL] [Abstract][Full Text] [Related]
34. Synaptopodin expression in idiopathic nephrotic syndrome of childhood.
Srivastava T; Garola RE; Whiting JM; Alon US
Kidney Int; 2001 Jan; 59(1):118-25. PubMed ID: 11135064
[TBL] [Abstract][Full Text] [Related]
35. Apolipoprotein E polymorphism in childhood nephrotic syndrome.
Attila G; Noyan A; Karabay Bayazit A; Acartürk E; Anarat A
Pediatr Nephrol; 2002 May; 17(5):359-62. PubMed ID: 12042894
[TBL] [Abstract][Full Text] [Related]
36. Fractional excretion of IgG predicts renal outcome and response to therapy in primary focal segmental glomerulosclerosis: a pilot study.
Bazzi C; Petrini C; Rizza V; Napodano P; Paparella M; Arrigo G; Pisano L; D'Amico G
Am J Kidney Dis; 2003 Feb; 41(2):328-35. PubMed ID: 12552493
[TBL] [Abstract][Full Text] [Related]
37. Messenger RNA expression of B7-1 and NPHS1 in urinary sediment could be useful to differentiate between minimal-change disease and focal segmental glomerulosclerosis in adult patients.
Navarro-Muñoz M; Ibernon M; Pérez V; Ara J; Espinal A; López D; Bonet J; Romero R
Nephrol Dial Transplant; 2011 Dec; 26(12):3914-23. PubMed ID: 21414970
[TBL] [Abstract][Full Text] [Related]
38. MDR-1 gene polymorphisms in steroid-responsive versus steroid-resistant nephrotic syndrome in children.
Jafar T; Prasad N; Agarwal V; Mahdi A; Gupta A; Sharma RK; Negi MP; Agrawal S
Nephrol Dial Transplant; 2011 Dec; 26(12):3968-74. PubMed ID: 21460357
[TBL] [Abstract][Full Text] [Related]
39. Treatment of adult idiopathic nephrotic syndrome with cyclosporin A: minimal-change disease and focal-segmental glomerulosclerosis. Collaborative Group of the French Society of Nephrology.
Meyrier A; Condamin MC; Broneer D
Clin Nephrol; 1991; 35 Suppl 1():S37-42. PubMed ID: 1860266
[TBL] [Abstract][Full Text] [Related]
40. Rituximab in minimal change nephropathy and focal segmental glomerulosclerosis: report of four cases and review of the literature.
Peters HP; van de Kar NC; Wetzels JF
Neth J Med; 2008 Nov; 66(10):408-15. PubMed ID: 19011266
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
